Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib and paclitaxel in recurrent or metastatic gastric cancer
NCT01063517Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in gastric cancer (GC), sponsored by AstraZeneca. Started Feb 2010; status: completed.
02
Drugs
olaparib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01063517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063517.